Bayer issued an apology for two tweets about the erectile dysfunction drug Levitra and multiple sclerosis therapy Sativex further enforcing the need for FDA to issue official social media guidance.
The apology, to be published in the August review of the U.K.’s Prescription Medicines Code of Practice Authority, came after Bayer published two comments on Twitter, in March 2011 and June 2010, that did not appear to have been written by lawyers or compliance officers. One referred to Bayer’s new melt-in-the-mouth version of Levitra.
To finish this Bnet article and view the offending tweets click here.